BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26107198)

  • 1. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
    Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
    Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
    Ma C; Liu Y; Zhang W; Liu P
    Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis.
    Yan Y; Han F; Fu H; Xia W; Qin X
    Tumour Biol; 2014 Aug; 35(8):7707-12. PubMed ID: 24805831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between the C677T polymorphism in MTHFR gene and the risk of thyroid cancer: a meta-analysis.
    Yang YM; Zhang TT; Yuan L; Ren Y
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2097-101. PubMed ID: 25070812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase C677T polymorphism and cervical cancer risk: a meta-analysis.
    Guo LN
    Asian Pac J Cancer Prev; 2012; 13(5):2193-7. PubMed ID: 22901193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of C677T polymorphism (rs1801133) in MTHFR gene with depression.
    Rai V
    Cell Mol Biol (Noisy-le-grand); 2017 Jul; 63(6):60-67. PubMed ID: 28968218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis.
    Rai V
    Mol Neurobiol; 2017 Mar; 54(2):1173-1186. PubMed ID: 26820674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between MTHFR C677T Gene polymorphism with alcohol dependence: A meta-analysis of case-control studies.
    Xu R; Wu H; Zhang S; Zhou H; Liang L
    Neurosci Lett; 2018 Sep; 683():69-74. PubMed ID: 29953924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
    Yi K; Yang L; Lan Z; Xi M
    Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the methylenetetrahydrofolate reductase gene C677T polymorphism with the risk of male infertility: a meta-analysis.
    Zhu X; Liu Z; Zhang M; Gong R; Xu Y; Wang B
    Ren Fail; 2016; 38(2):185-93. PubMed ID: 26584688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant association between MTHFR C677T polymorphism and thyroid cancer risk: evidence from a meta-analysis.
    Chen Y; Wang B; Yan S; Wang YG
    Genet Test Mol Biomarkers; 2014 Oct; 18(10):695-702. PubMed ID: 25007377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of MTHFR C677T and A1298C Polymorphisms on Migraine Susceptibility: A Meta-Analysis of 26 Studies.
    Liu L; Yu Y; He J; Guo L; Li H; Teng J
    Headache; 2019 Jun; 59(6):891-905. PubMed ID: 31045246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls.
    Zhang WB; Zhang JH; Pan ZQ; Yang QS; Liu B
    Asian Pac J Cancer Prev; 2012; 13(6):2597-604. PubMed ID: 22938427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.
    Chen PL; Li WT; Wang J; Jiang YD; Wu P; Chen T; Zheng SB
    Genet Mol Res; 2015 Dec; 14(4):19191-202. PubMed ID: 26782572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis.
    Ding XP; Feng L; Ma L
    Asian Pac J Cancer Prev; 2012; 13(8):3937-42. PubMed ID: 23098496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.
    Guo S; Jiang X; Chen X; Chen L; Li X; Jia Y
    Gene; 2015 Jul; 565(1):90-5. PubMed ID: 25841988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the MTHFR C677T Polymorphism as a Risk Factor for Colorectal Cancer in Asian Populations.
    Rai V
    Asian Pac J Cancer Prev; 2015; 16(18):8093-100. PubMed ID: 26745044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between
    Tan X; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1273218. PubMed ID: 37964957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.
    Wu YL; Yang HY; Ding XX; Zhao X; Chen J; Bi P; Sun YH
    Seizure; 2014 Jun; 23(6):411-6. PubMed ID: 24556013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.